Effects of Cost Sharing on Ophthalmic Care Utilization in the Affordable Care Act Marketplace.

IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Ophthalmic epidemiology Pub Date : 2024-04-01 Epub Date: 2023-04-12 DOI:10.1080/09286586.2023.2199849
Jeremy B Hatcher, George Lin, Cullen P Moran, Sara Al Hussein Al Awamlh, Lina Sulieman, Natalia G Morales, Sean T Berkowitz, Shriji Patel, Jennifer Lindsey
{"title":"Effects of Cost Sharing on Ophthalmic Care Utilization in the Affordable Care Act Marketplace.","authors":"Jeremy B Hatcher, George Lin, Cullen P Moran, Sara Al Hussein Al Awamlh, Lina Sulieman, Natalia G Morales, Sean T Berkowitz, Shriji Patel, Jennifer Lindsey","doi":"10.1080/09286586.2023.2199849","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To determine the distribution and quantity of ophthalmic care consumed on Affordable Care Act (ACA) plans, the demographics of the population utilizing these services, and the relationship between ACA insurance coverage plan tier, cost sharing, and total cost of ophthalmic care consumed.</p><p><strong>Methods: </strong>This cross-sectional study analyzed ACA individual and small group market claims data from the Wakely Affordable Care Act (WACA) 2018 dataset, which contains detailed claims, enrollment, and premium data from Edge Servers for 3.9 million individual and small group market lives. We identified all enrollees with ophthalmology-specific billing, procedure, and national drug codes. We then analyzed the claims by plan type and calculated the total cost and out-of-pocket (OOP) cost.</p><p><strong>Results: </strong>Among 3.9 million enrollees in the WACA 2018 dataset, 538,169 (13.7%) had claims related to ophthalmology procedures, medications, and/or diagnoses. A total of $203 million was generated in ophthalmology-related claims, with $54 million in general services, $42 million in medications, $20 million in diagnostics and imaging, and $86 million in procedures. Average annual OOP costs were $116 per member, or 30.9% of the total cost, and were lowest for members with platinum plans (16% OOP) and income-driven cost sharing reduction (ICSR) subsidies (17% OOP). Despite stable ocular disease distribution across plan types, beneficiaries with silver ICSR subsidies consumed more total care than any other plan, higher than platinum plan enrollees and almost 1.5× the cost of bronze plan enrollees.</p><p><strong>Conclusions: </strong>Ophthalmic care for enrollees on ACA plans generated substantial costs in 2018. Plans with higher OOP cost sharing may result in lower utilization of ophthalmic care.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"159-168"},"PeriodicalIF":1.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2023.2199849","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To determine the distribution and quantity of ophthalmic care consumed on Affordable Care Act (ACA) plans, the demographics of the population utilizing these services, and the relationship between ACA insurance coverage plan tier, cost sharing, and total cost of ophthalmic care consumed.

Methods: This cross-sectional study analyzed ACA individual and small group market claims data from the Wakely Affordable Care Act (WACA) 2018 dataset, which contains detailed claims, enrollment, and premium data from Edge Servers for 3.9 million individual and small group market lives. We identified all enrollees with ophthalmology-specific billing, procedure, and national drug codes. We then analyzed the claims by plan type and calculated the total cost and out-of-pocket (OOP) cost.

Results: Among 3.9 million enrollees in the WACA 2018 dataset, 538,169 (13.7%) had claims related to ophthalmology procedures, medications, and/or diagnoses. A total of $203 million was generated in ophthalmology-related claims, with $54 million in general services, $42 million in medications, $20 million in diagnostics and imaging, and $86 million in procedures. Average annual OOP costs were $116 per member, or 30.9% of the total cost, and were lowest for members with platinum plans (16% OOP) and income-driven cost sharing reduction (ICSR) subsidies (17% OOP). Despite stable ocular disease distribution across plan types, beneficiaries with silver ICSR subsidies consumed more total care than any other plan, higher than platinum plan enrollees and almost 1.5× the cost of bronze plan enrollees.

Conclusions: Ophthalmic care for enrollees on ACA plans generated substantial costs in 2018. Plans with higher OOP cost sharing may result in lower utilization of ophthalmic care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
费用分摊对平价医疗法案市场中眼科医疗使用的影响。
目的:确定在《平价医疗法案》(ACA)计划中消费的眼科护理的分布和数量、使用这些服务的人群的人口统计学特征,以及《平价医疗法案》保险计划层级、费用分担和消费的眼科护理总费用之间的关系:这项横断面研究分析了 Wakely Affordable Care Act (WACA) 2018 数据集中的 ACA 个人和小型团体市场理赔数据,该数据集包含 Edge Servers 提供的 390 万个人和小型团体市场生命的详细理赔、注册和保费数据。我们确定了所有具有眼科特定账单、程序和国家药品代码的参保者。然后,我们按计划类型对索赔进行了分析,并计算了总费用和自付费用 (OOP):在 WACA 2018 数据集中的 390 万参保者中,有 538,169 人(13.7%)的理赔与眼科手术、药物和/或诊断有关。与眼科相关的理赔总额为 2.03 亿美元,其中普通服务 5,400 万美元,药物 4,200 万美元,诊断和成像 2,000 万美元,手术 8,600 万美元。每位会员的年平均 OOP 费用为 116 美元,占总费用的 30.9%,其中白金计划(OOP 费用占 16%)和收入驱动的费用分担减少(ICSR)补贴(OOP 费用占 17%)会员的 OOP 费用最低。尽管眼科疾病在不同计划类型中的分布比较稳定,但享受银质 ICSR 补贴的受益人比其他任何计划的受益人消耗的护理总费用都要高,高于白金计划的参保人,几乎是青铜计划参保人费用的 1.5 倍:2018 年,ACA 计划参保者的眼科护理产生了大量费用。OOP费用分担较高的计划可能会导致眼科护理的使用率降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ophthalmic epidemiology
Ophthalmic epidemiology 医学-眼科学
CiteScore
3.70
自引率
5.60%
发文量
61
审稿时长
6-12 weeks
期刊介绍: Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.
期刊最新文献
Evaluation of a Risk Screening Tool for Retinopathy of Prematurity (ROP) in a German Cohort. Feasibility and Patient Experience of a Pilot Artificial Intelligence-Based Diabetic Retinopathy Screening Program in Northern Ontario. Binocular Visual Field Loss and Crash Risk: An eFOVID Population-Based Study. Prevalence of Diabetic Retinopathy and Dilated Fundus Examinations by Metropolitan Status from 2017-2021: An Assessment of the Behavioral Risk Factor Surveillance System. Weather Patterns, Patient, and Appointment Characteristics Associated with Cancellations and No-Shows in a Glaucoma Clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1